在频繁的全血献血者中进行克隆性血液形成
1Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO.
Hematology. American Society of Hematology. Education Program
|December 9, 2023
概括
频繁的献血可能会增加克隆性血液形成 (CH),因为DNMT3A和TET2.2等表观遗传修饰物的突变. 红色素 (EPO) 可能为这些突变干细胞提供一个健身优势.
科学领域:
- 血液学 血液学 血液学
- 干细胞生物学 干细胞生物学
- 遗传学 是一个遗传学.
背景情况:
- 重复的全血捐献会诱导造血压力,可能改变造血干细胞 (HSC) 的行为.
- 这种压力可能导致克隆性血液形成 (CH),其特征是HSCs随着体质突变的扩张.
- CH与年龄相关,并且可能涉及与表观遗传修饰相关的基因突变.
研究的目的:
- 调查频繁献血者中CH的患病率和特征.
- 探索特定突变与细胞对环境触发的反应之间的潜在联系.
- 评估与白血病前突变有关的重复献血的安全性.
主要方法:
- 与对照队伍相比,频繁献血者中CH患病率的分析.
- 在编码表观遗传修饰剂的基因中识别常见突变 (例如,DNMT3A,TET2).
- 功能性测试用于评估在特定突变存在的情况下,HSC对 erythropoietin (EPO) 和炎症介质的反应.
主要成果:
- 经常献血的献血者显示CH的患病率更高,主要是由DNMT3A和TET2.2中低风险突变驱动的.
- 在频繁捐献者和对照者之间没有观察到已知的白血病前驱动突变的显著差异,这表明捐赠安全.
- 特定的DNMT3A突变与提高HSC对红色素 (EPO) 的反应性有关,但与炎症无关.
结论:
- 重复献血可以促进特定突变HSC的扩张,特别是那些具有DNMT3A突变的HSC.
- 红色素 (EPO) 作为环境因素,为这些突变的高血压细胞提供了健康优势.
- 进一步分析不同捐赠群体中CH的情况,对于对不同类型捐赠进行全面的健康风险评估至关重要.
相关概念视频
Hematopoiesis
5.3K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.3K
Bone Marrow Sampling and Transplants
333
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
333
Overview of Hematopoiesis
4.0K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
4.0K
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
Production of Formed Elements
1.4K
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...
1.4K
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K


